Need help finding what you are looking for?
Contact Us
PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 1320204
PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 1320204
Biopharmaceutical CMO And CRO Market with COVID-19 Impact Analysis, By Product Type, Source, By Service Type, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2023-2030
PUBLISHED:
PAGES: 241 Pages
DELIVERY TIME: 2-3 business days
SELECT AN OPTION
REPORT HIGHLIGHT
Biopharmaceutical CMO And CRO Market size was valued at USD 32,478.3 Million in 2022, expanding at a CAGR of 5.5% from 2023 to 2030.
Biopharmaceutical CMO (Contract Manufacturing Organization) and CRO (Contract Research Organization) are specialized service providers within the biopharmaceutical industry that offer outsourcing solutions to biopharmaceutical companies. These CMOs have specialized facilities and expertise to manufacture a wide range of biopharmaceuticals, including biologics, vaccines, gene therapies, and other complex biological products. Biopharmaceutical CMOs play a crucial role in the production of these advanced therapeutics, as they often require sophisticated and specialized manufacturing processes. CROs on the other hand provide research and development support, conducting various phases of preclinical and clinical trials, as well as other research activities. Biopharmaceutical CROs play a critical role in advancing the drug development process by providing expertise, resources, and infrastructure for conducting clinical trials and other research studies
Biopharmaceutical CMO And CRO Market- Market Dynamics:
Rapid growth of biopharmaceutical industry is expected to propel the market demand
The year 2020 witnessed remarkable growth, primarily attributed to the impact of the COVID-19 pandemic. Prominent participants in the biopharmaceutical industry increased their investments to improve productivity and efficiency, leading bio manufacturers to shift their focus towards outsourcing activities. Currently, biopharma companies are outsourcing resource and capital-intensive steps, and in some instances, the entire biomanufacturing process, thus driving the demand for contract-based services. In recent years, the biopharmaceutical industry has experienced a significant number of consolidations, primarily driven by the aim of expanding businesses and maintaining competitiveness in the biopharmaceutical contract manufacturing and services market. While the biopharmaceutical CMO & CRO industry itself is relatively mature, the introduction of new bioprocessing tools, innovative therapeutics, and shifting priorities in the bio/pharmaceutical industry have placed additional pressure on contract biomanufacturers. Consequently, CDMOs are adopting various business models to effectively address the needs of their clients and stakeholders. Moreover, the incorporation of single-use systems in production facilities allows CMOs to economically expand their manufacturing capacity. Single-use products offer rapid turnaround times and reduce associated tasks such as cleaning and changeover validation. However, contract negotiations between CMOs and customers can be challenging due to the complexities of the regulatory landscape and services involved. Issues related to intellectual property rights, warranties & liabilities, pricing, and timelines add further complexity to these negotiations for both clients and CMOs.
Biopharmaceutical CMO And CRO Market- Key Insights:
- As per the analysis shared by our research analyst, the global Biopharmaceutical CMO And CRO market is estimated to grow annually at a CAGR of around 5.5% over the forecast period (2023-2030)
- The Biopharmaceutical CMO And CRO industry is projected to grow at due to rapid growth of biopharmaceutical industry
- Based on source type, mammalian was predicted to show maximum market share in the year 2022
- Based on service type, Contract Manufacturing was the leading type in 2022
- On the basis of region, North America was the leading revenue generator in 2022
Biopharmaceutical CMO And CRO Market- Segmentation Analysis:
The Global Biopharmaceutical CMO And CRO Market is segmented on the basis of Product Type, By Source, By Service Type, and Region.
The market is divided into two categories based on Source Type: mammalian and non- mammalian. In 2022, the mammalian segment dominated the market with a significant market share. This is mainly due to the industry's limited internal expertise, driving companies to rely on mammalian systems for their ability to introduce human-like post-translational modifications to complex protein therapeutics. Additionally, the segment has greatly benefited from the introduction of advanced expression systems, improved process monitoring solutions, cell line engineering tools, automated screening methods, and disposable devices, further bolstering its growth and success.
The market is divided into two categories based on Service type: Contract Manufacturing and Contract research. In 2022, the Contract Manufacturing segment accounted for the largest market share. On the other hand, the Contract Research segment is projected to experience the fastest CAGR during the forecast period. This growth is primarily driven by the increasing trend of biopharmaceutical companies outsourcing their research activities. Within the industry, there is a significant number of Contract Manufacturing Organizations (CMOs) and opportunistic CMOs that offer a wide array of services to biopharmaceutical entities. These services range from end-to-end coverage, starting from cell cultivation to fill/finish services. Additionally, clients are heavily investing in outsourcing the manufacturing aspect of their product development programs. This increased focus on outsourcing is contributing to the rapid growth of the Contract Research segment.
Biopharmaceutical CMO And CRO Market- Geographical Insights:
Geographically, this market is widespread into the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided as per the nations bringing business.
Biopharmaceutical CMO And CRO Market- Competitive Landscape:
The market exhibits a fragmented structure as it comprises a significant number of established and medium-to-small-sized CMOs and CROs. Many of these market participants are privately held or fall under the portfolios of private equity firms. In order to enhance project throughput and product quality, CMOs are increasingly adopting automation and innovative technologies at their facilities. As a result, large molecule manufacturers are becoming more interested in collaborating with CMOs to meet the rising demand for biologics.
Recent Developments:
In March 2023, Hanmi Pharmaceutical has announced its intention to take part in the 2023 BIO-Europe Spring Conference, where it will formally launch its CMO (contract manufacturing organization) and CDMO (contract development and manufacturing organization) business activities.
Key features of the study:
- This proposed research study on Biopharmaceutical CMO And CRO market provides market size (US$ million), compound annual growth rate (CAGR %) and forecast estimation (2023-2030), considering 2022 as the base year
- The report provides the client the latest up-to-date and trending insights about the Biopharmaceutical CMO And CRO market.
- The research report elucidates potential growth opportunities across different segments/countries and explains attractive investment proposition matrix for Biopharmaceutical CMO And CRO market
- The overall report identifies new investment opportunities, challenges faced by established players, and growth factors to sustain in the Biopharmaceutical CMO And CRO market
- Impact of COVID-19 on Biopharmaceutical CMO And CRO market size, forecast, CAGR, and market dynamics are discussed in detail under the research scope. Detailed insight on Biopharmaceutical CMO And CRO market post-COVID will also be covered.
- In order to give the users of this report a comprehensive view on the Biopharmaceutical CMO And CRO market, we have also included competitive landscape and key innovator analysis for the Biopharmaceutical CMO And CRO market.
- The study encompasses a growth prospect mapping analysis, wherein all the industry segments are benchmarked based on their market size, growth rate and attractiveness.
- The report offers detailed company profiling featuring major market participants which will help users to understand their financial information and strategic initiatives of players operating in the Biopharmaceutical CMO And CRO market.
- In addition, the report also unveil the important acquisitions & mergers, collaborations & joint ventures, new launch, research & development, regional expansion of major participants involved in the market on global as well as regional level.
- The global Biopharmaceutical CMO And CRO market report primarily caters to various stakeholders in this industry including suppliers, investors, new entrants, distributors, and financial analysts
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
GLOBAL BIOPHARMACEUTICAL CMO AND CRO MARKET KEY PLAYERS
- Boehringer Ingelheim GmbH
- Lonza Group AG
- Inno Biologics Sdn Bhd
- Rentschler Biopharma SE
- JRS Pharma
- Biomeva GmbH
- ProBioGen AG
- Fujifilm Diosynth Biotechnologies U.S.A., Inc.
- Toyobo Co., Ltd.
- Samsung Biologics
- Thermo Fisher Scientific Inc (Patheon & PPD)
- CMC Biologics
- WuXi Biologics
- AbbVie Inc.
- Binex Co., Ltd.
- Charles River Laboratories International, Inc.
- ICON Plc
GLOBAL BIOPHARMACEUTICAL CMO AND CRO MARKET, BY PRODUCT TYPE
- Biologics
- Biosimilars
GLOBAL BIOPHARMACEUTICAL CMO AND CRO MARKET, BY SOURCE
- Mammalian
- Non-mammalian
GLOBAL BIOPHARMACEUTICAL CMO AND CRO MARKET, BY SERVICE TYPE
- Contract Manufacturing
- Contract Research
GLOBAL BIOPHARMACEUTICAL CMO AND CRO MARKET, BY REGION
- North America
- The U.S.
- Canada
- Europe
- Germany
- France
- Italy
- Spain
- United Kingdom
- Russia
- Netherlands
- Sweden
- Poland
- Rest of Europe
- Asia Pacific
- India
- China
- South Korea
- Japan
- Australia
- Thailand
- Indonesia
- Philippines
- Rest of APAC
- Latin America
- Brazil
- Mexico
- Argentina
- Colombia
- Rest of LATAM
- The Middle East and Africa
- Saudi Arabia
- United Arab Emirates
- Israel
- Turkey
- Algeria
- Egypt
- Rest of MEA
Product Code: ANV1515
Table of Contents
1. Biopharmaceutical CMO And CRO Market Overview
- 1.1. Study Scope
- 1.2. Market Estimation Years
2. Executive Summary
- 2.1. Market Snippet
- 2.1.1. Biopharmaceutical CMO And CRO Market Snippet by Product type
- 2.1.2. Biopharmaceutical CMO And CRO Market Snippet by Source
- 2.1.3. Biopharmaceutical CMO And CRO Market Snippet by Service Type
- 2.1.4. Biopharmaceutical CMO And CRO Market Snippet by Country
- 2.1.5. Biopharmaceutical CMO And CRO Market Snippet by Region
- 2.2. Competitive Insights
3. Biopharmaceutical CMO And CRO Key Market Trends
- 3.1. Biopharmaceutical CMO And CRO Market Drivers
- 3.1.1. Impact Analysis of Market Drivers
- 3.2. Biopharmaceutical CMO And CRO Market Restraints
- 3.2.1. Impact Analysis of Market Restraints
- 3.3. Biopharmaceutical CMO And CRO Market Opportunities
- 3.4. Biopharmaceutical CMO And CRO Market Future Trends
4. Biopharmaceutical CMO And CRO Industry Study
- 4.1. PEST Analysis
- 4.2. Porter's Five Forces Analysis
- 4.3. Growth Prospect Mapping
- 4.4. Regulatory Framework Analysis
5. Biopharmaceutical CMO And CRO Market: COVID-19 Impact Analysis
- 5.1. Pre-COVID-19 Impact Analysis
- 5.2. Post-COVID-19 Impact Analysis
- 5.2.1. Top Performing Segments
- 5.2.2. Marginal Growth Segments
- 5.2.3. Top Looser Segments
- 5.2.4. Marginal Loss Segments
6. Biopharmaceutical CMO And CRO Market Landscape
- 6.1. Biopharmaceutical CMO And CRO Market Share Analysis, 2022
- 6.2. Breakdown Data, by Key Manufacturer
- 6.2.1. Established Players' Analysis
- 6.2.2. Emerging Players' Analysis
7. Biopharmaceutical CMO And CRO Market - By Product type
- 7.1. Overview
- 7.1.1. Segment Share Analysis, By Product type, 2022 & 2030 (%)
- 7.1.2. Biologics
- 7.1.3. Biosimilars
8. Biopharmaceutical CMO And CRO Market - By Source
- 8.1. Overview
- 8.1.1. Segment Share Analysis, By Source, 2022 & 2030 (%)
- 8.1.2. Mammalian
- 8.1.3. Non-mammalian
9. Biopharmaceutical CMO And CRO Market - By Service Type
- 9.1. Overview
- 9.1.1. Segment Share Analysis, By Service Type, 2022 & 2030 (%)
- 9.1.2. Contract Manufacturing
- 9.1.3. Contract Research
10. Biopharmaceutical CMO And CRO Market- By Geography
- 10.1. Introduction
- 10.1.1. Segment Share Analysis, By Geography, 2022 & 2030 (%)
- 10.2. North America
- 10.2.1. Overview
- 10.2.2. Biopharmaceutical CMO And CRO Key Manufacturers in North America
- 10.2.3. North America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
- 10.2.4. North America Market Size and Forecast, By Product type, 2018 - 2030 (US$ Million)
- 10.2.5. North America Market Size and Forecast, By Source, 2018 - 2030 (US$ Million)
- 10.2.6. North America Market Size and Forecast, By Service Type, 2018 - 2030 (US$ Million)
- 10.2.7. U.S.
- 10.2.7.1. Overview
- 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.2.7.3. U.S. Market Size and Forecast, By Product type, 2018 - 2030 (US$ Million)
- 10.2.7.4. U.S. Market Size and Forecast, By Source, 2018 - 2030 (US$ Million)
- 10.2.7.5. U.S. Market Size and Forecast, By Service Type, 2018 - 2030 (US$ Million)
- 10.2.8. Canada
- 10.2.8.1. Overview
- 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.2.8.3. Canada Market Size and Forecast, By Product type, 2018 - 2030 (US$ Million)
- 10.2.8.4. Canada Market Size and Forecast, By Source, 2018 - 2030 (US$ Million)
- 10.2.8.5. Canada Market Size and Forecast, By Service Type, 2018 - 2030 (US$ Million)
- 10.3. Europe
- 10.3.1. Overview
- 10.3.2. Biopharmaceutical CMO And CRO Key Manufacturers in Europe
- 10.3.3. Europe Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
- 10.3.4. Europe Market Size and Forecast, By Product type, 2018 - 2030 (US$ Million)
- 10.3.5. Europe Market Size and Forecast, By Source, 2018 - 2030 (US$ Million)
- 10.3.6. Europe Market Size and Forecast, By Service Type, 2018 - 2030 (US$ Million)
- 10.3.7. Germany
- 10.3.7.1. Overview
- 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.3.7.3. Germany Market Size and Forecast, By Product type, 2018 - 2030 (US$ Million)
- 10.3.7.4. Germany Market Size and Forecast, By Source, 2018 - 2030 (US$ Million)
- 10.3.7.5. Germany Market Size and Forecast, By Service Type, 2018 - 2030 (US$ Million)
- 10.3.8. Italy
- 10.3.8.1. Overview
- 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.3.8.3. Italy Market Size and Forecast, By Product type, 2018 - 2030 (US$ Million)
- 10.3.8.4. Italy Market Size and Forecast, By Source, 2018 - 2030 (US$ Million)
- 10.3.8.5. Italy Market Size and Forecast, By Service Type, 2018 - 2030 (US$ Million)
- 10.3.9. United Kingdom
- 10.3.9.1. Overview
- 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.3.9.3. United Kingdom Market Size and Forecast, By Product type, 2018 - 2030 (US$ Million)
- 10.3.9.4. United Kingdom Market Size and Forecast, By Source, 2018 - 2030 (US$ Million)
- 10.3.9.5. United Kingdom Market Size and Forecast, By Service Type, 2018 - 2030 (US$ Million)
- 10.3.10. France
- 10.3.10.1. Overview
- 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.3.10.3. France Market Size and Forecast, By Product type, 2018 - 2030 (US$ Million)
- 10.3.10.4. France Market Size and Forecast, By Source, 2018 - 2030 (US$ Million)
- 10.3.10.5. France Market Size and Forecast, By Service Type, 2018 - 2030 (US$ Million)
- 10.3.11. Russia
- 10.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.3.11.2. Russia Market Size and Forecast, By Product type, 2018 - 2030 (US$ Million)
- 10.3.11.3. Russia Market Size and Forecast, By Source, 2018 - 2030 (US$ Million)
- 10.3.11.4. Russia Market Size and Forecast, By Service Type, 2018 - 2030 (US$ Million)
- 10.3.12. Netherlands
- 10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.3.12.2. Netherlands Market Size and Forecast, By Product type, 2018 - 2030 (US$ Million)
- 10.3.12.3. Netherlands Market Size and Forecast, By Source, 2018 - 2030 (US$ Million)
- 10.3.12.4. Netherlands Market Size and Forecast, By Service Type, 2018 - 2030 (US$ Million)
- 10.3.13. Sweden
- 10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.3.13.2. Sweden Market Size and Forecast, By Product type, 2018 - 2030 (US$ Million)
- 10.3.13.3. Sweden Market Size and Forecast, By Source, 2018 - 2030 (US$ Million)
- 10.3.13.4. Sweden Market Size and Forecast, By Service Type, 2018 - 2030 (US$ Million)
- 10.3.14. Poland
- 10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.3.14.2. Poland Market Size and Forecast, By Product type, 2018 - 2030 (US$ Million)
- 10.3.14.3. Poland Market Size and Forecast, By Source, 2018 - 2030 (US$ Million)
- 10.3.14.4. Poland Market Size and Forecast, By Service Type, 2018 - 2030 (US$ Million)
- 10.3.15. Rest of Europe
- 10.3.15.1. Overview
- 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.3.15.3. Rest of the Europe Market Size and Forecast, By Product type, 2018 - 2030 (US$ Million)
- 10.3.15.4. Rest of the Europe Market Size and Forecast, By Source, 2018 - 2030 (US$ Million)
- 10.3.15.5. Rest of the Europe Market Size and Forecast, By Service Type, 2018 - 2030 (US$ Million)
- 10.4. Asia Pacific (APAC)
- 10.4.1. Overview
- 10.4.2. Biopharmaceutical CMO And CRO Key Manufacturers in Asia Pacific
- 10.4.3. Asia Pacific Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
- 10.4.4. Asia Pacific Market Size and Forecast, By Product type, 2018 - 2030 (US$ Million)
- 10.4.5. Asia Pacific Market Size and Forecast, By Source, 2018 - 2030 (US$ Million)
- 10.4.6. Asia Pacific Market Size and Forecast, By Service Type, 2018 - 2030 (US$ Million)
- 10.4.7. India
- 10.4.7.1. Overview
- 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.4.7.3. India Market Size and Forecast, By Product type, 2018 - 2030 (US$ Million)
- 10.4.7.4. India Market Size and Forecast, By Source, 2018 - 2030 (US$ Million)
- 10.4.7.5. India Market Size and Forecast, By Service Type, 2018 - 2030 (US$ Million)
- 10.4.8. China
- 10.4.8.1. Overview
- 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.4.8.3. China Market Size and Forecast, By Product type, 2018 - 2030 (US$ Million)
- 10.4.8.4. China Market Size and Forecast, By Source, 2018 - 2030 (US$ Million)
- 10.4.8.5. China Market Size and Forecast, By Service Type, 2018 - 2030 (US$ Million)
- 10.4.9. Japan
- 10.4.9.1. Overview
- 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.4.9.3. Japan Market Size and Forecast, By Product type, 2018 - 2030 (US$ Million)
- 10.4.9.4. Japan Market Size and Forecast, By Source, 2018 - 2030 (US$ Million)
- 10.4.9.5. Japan Market Size and Forecast, By Service Type, 2018 - 2030 (US$ Million)
- 10.4.10. South Korea
- 10.4.10.1. Overview
- 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.4.10.3. South Korea Market Size and Forecast, By Product type, 2018 - 2030 (US$ Million)
- 10.4.10.4. South Korea Market Size and Forecast, By Source, 2018 - 2030 (US$ Million)
- 10.4.10.5. South Korea Market Size and Forecast, By Service Type, 2018 - 2030 (US$ Million)
- 10.4.11. Australia
- 10.4.11.1. Overview
- 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.4.11.3. Australia Market Size and Forecast, By Product type, 2018 - 2030 (US$ Million)
- 10.4.11.4. Australia Market Size and Forecast, By Source, 2018 - 2030 (US$ Million)
- 10.4.11.5. Australia Market Size and Forecast, By Service Type, 2018 - 2030 (US$ Million)
- 10.4.12. Thailand
- 10.4.12.1. Overview
- 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.4.12.3. Thailand Market Size and Forecast, By Product type, 2018 - 2030 (US$ Million)
- 10.4.12.4. Thailand Market Size and Forecast, By Source, 2018 - 2030 (US$ Million)
- 10.4.12.5. Thailand Market Size and Forecast, By Service Type, 2018 - 2030 (US$ Million)
- 10.4.13. Indonesia
- 10.4.13.1. Overview
- 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.4.13.3. Indonesia Market Size and Forecast, By Product type, 2018 - 2030 (US$ Million)
- 10.4.13.4. Indonesia Market Size and Forecast, By Source, 2018 - 2030 (US$ Million)
- 10.4.13.5. Indonesia Market Size and Forecast, By Service Type, 2018 - 2030 (US$ Million)
- 10.4.14. Philippines
- 10.4.14.1. Overview
- 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.4.14.3. Philippines Market Size and Forecast, By Product type, 2018 - 2030 (US$ Million)
- 10.4.14.4. Philippines Market Size and Forecast, By Source, 2018 - 2030 (US$ Million)
- 10.4.14.5. Philippines Market Size and Forecast, By Service Type, 2018 - 2030 (US$ Million)
- 10.4.15. Rest of APAC
- 10.4.15.1. Overview
- 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.4.15.3. Rest of APAC Market Size and Forecast, By Product type, 2018 - 2030 (US$ Million)
- 10.4.15.4. Rest of APAC Market Size and Forecast, By Source, 2018 - 2030 (US$ Million)
- 10.4.15.5. Rest of APAC Market Size and Forecast, By Service Type, 2018 - 2030 (US$ Million)
- 10.5. Latin America
- 10.5.1. Overview
- 10.5.2. Biopharmaceutical CMO And CRO Key Manufacturers in Latin America
- 10.5.3. Latin America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
- 10.5.4. Latin America Market Size and Forecast, By Product type, 2018 - 2030 (US$ Million)
- 10.5.5. Latin America Market Size and Forecast, By Source, 2018 - 2030 (US$ Million)
- 10.5.6. Latin America Market Size and Forecast, By Service Type, 2018 - 2030 (US$ Million)
- 10.5.7. Brazil
- 10.5.7.1. Overview
- 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.5.7.3. Brazil Market Size and Forecast, By Product type, 2018 - 2030 (US$ Million)
- 10.5.7.4. Brazil Market Size and Forecast, By Source, 2018 - 2030 (US$ Million)
- 10.5.7.5. Brazil Market Size and Forecast, By Service Type, 2018 - 2030 (US$ Million)
- 10.5.8. Mexico
- 10.5.8.1. Overview
- 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.5.8.3. Mexico Market Size and Forecast, By Product type, 2018 - 2030 (US$ Million)
- 10.5.8.4. Mexico Market Size and Forecast, By Source, 2018 - 2030 (US$ Million)
- 10.5.8.5. Mexico Market Size and Forecast, By Service Type, 2018 - 2030 (US$ Million)
- 10.5.9. Argentina
- 10.5.9.1. Overview
- 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.5.9.3. Argentina Market Size and Forecast, By Product type, 2018 - 2030 (US$ Million)
- 10.5.9.4. Argentina Market Size and Forecast, By Source, 2018 - 2030 (US$ Million)
- 10.5.9.5. Argentina Market Size and Forecast, By Service Type, 2018 - 2030 (US$ Million)
- 10.5.10. Colombia
- 10.5.10.1. Overview
- 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.5.10.3. Colombia Market Size and Forecast, By Product type, 2018 - 2030 (US$ Million)
- 10.5.10.4. Colombia Market Size and Forecast, By Source, 2018 - 2030 (US$ Million)
- 10.5.10.5. Colombia Market Size and Forecast, By Service Type, 2018 - 2030 (US$ Million)
- 10.5.11. Rest of LATAM
- 10.5.11.1. Overview
- 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.5.11.3. Rest of LATAM Market Size and Forecast, By Product type, 2018 - 2030 (US$ Million)
- 10.5.11.4. Rest of LATAM Market Size and Forecast, By Source, 2018 - 2030 (US$ Million)
- 10.5.11.5. Rest of LATAM Market Size and Forecast, By Service Type, 2018 - 2030 (US$ Million)
- 10.6. Middle East and Africa
- 10.6.1. Overview
- 10.6.2. Biopharmaceutical CMO And CRO Key Manufacturers in Middle East and Africa
- 10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
- 10.6.4. Middle East and Africa Market Size and Forecast, By Product type, 2018 - 2030 (US$ Million)
- 10.6.5. Middle East and Africa Market Size and Forecast, By Source, 2018 - 2030 (US$ Million)
- 10.6.6. Middle East and Africa Market Size and Forecast, By Service Type, 2018 - 2030 (US$ Million)
- 10.6.7. Saudi Arabia
- 10.6.7.1. Overview
- 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.6.7.3. Saudi Arabia Market Size and Forecast, By Product type, 2018 - 2030 (US$ Million)
- 10.6.7.4. Saudi Arabia Market Size and Forecast, By Source, 2018 - 2030 (US$ Million)
- 10.6.7.5. Saudi Arabia Market Size and Forecast, By Service Type, 2018 - 2030 (US$ Million)
- 10.6.8. United Arab Emirates
- 10.6.8.1. Overview
- 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.6.8.3. United Arab Emirates Market Size and Forecast, By Product type, 2018 - 2030 (US$ Million)
- 10.6.8.4. United Arab Emirates Market Size and Forecast, By Source, 2018 - 2030 (US$ Million)
- 10.6.8.5. United Arab Emirates Market Size and Forecast, By Service Type, 2018 - 2030 (US$ Million)
- 10.6.9. Israel
- 10.6.9.1. Overview
- 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.6.9.3. Israel Market Size and Forecast, By Product type, 2018 - 2030 (US$ Million)
- 10.6.9.4. Israel Market Size and Forecast, By Source, 2018 - 2030 (US$ Million)
- 10.6.9.5. Israel Market Size and Forecast, By Service Type, 2018 - 2030 (US$ Million)
- 10.6.10. Turkey
- 10.6.10.1. Overview
- 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.6.10.3. Turkey Market Size and Forecast, By Product type, 2018 - 2030 (US$ Million)
- 10.6.10.4. Turkey Market Size and Forecast, By Source, 2018 - 2030 (US$ Million)
- 10.6.10.5. Turkey Market Size and Forecast, By Service Type, 2018 - 2030 (US$ Million)
- 10.6.11. Algeria
- 10.6.11.1. Overview
- 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.6.11.3. Algeria Market Size and Forecast, By Product type, 2018 - 2030 (US$ Million)
- 10.6.11.4. Algeria Market Size and Forecast, By Source, 2018 - 2030 (US$ Million)
- 10.6.11.5. Algeria Market Size and Forecast, By Service Type, 2018 - 2030 (US$ Million)
- 10.6.12. Egypt
- 10.6.12.1. Overview
- 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.6.12.3. Egypt Market Size and Forecast, By Product type, 2018 - 2030 (US$ Million)
- 10.6.12.4. Egypt Market Size and Forecast, By Source, 2018 - 2030 (US$ Million)
- 10.6.12.5. Egypt Market Size and Forecast, By Service Type, 2018 - 2030 (US$ Million)
- 10.6.13. Rest of MEA
- 10.6.13.1. Overview
- 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.6.13.3. Rest of MEA Market Size and Forecast, By Product type, 2018 - 2030 (US$ Million)
- 10.6.13.4. Rest of MEA Market Size and Forecast, By Source, 2018 - 2030 (US$ Million)
- 10.6.13.5. Rest of MEA Market Size and Forecast, By Service Type, 2018 - 2030 (US$ Million)
11. Key Vendor Analysis- Biopharmaceutical CMO And CRO Industry
- 11.1. Competitive Dashboard
- 11.2. Company Profiles
- 11.2.1. Boehringer Ingelheim GmbH
- 11.2.2. Lonza Group AG
- 11.2.3. Inno Biologics Sdn Bhd
- 11.2.4. Rentschler Biopharma SE
- 11.2.5. JRS Pharma
- 11.2.6. Biomeva GmbH
- 11.2.7. ProBioGen AG
- 11.2.8. Fujifilm Diosynth Biotechnologies U.S.A., Inc.
- 11.2.9. Toyobo Co., Ltd.
- 11.2.10. Samsung Biologics
- 11.2.11. Thermo Fisher Scientific Inc (Patheon & PPD)
- 11.2.12. CMC Biologics
- 11.2.13. WuXi Biologics
- 11.2.14. AbbVie Inc.
- 11.2.15. Binex Co., Ltd.
- 11.2.16. Charles River Laboratories International, Inc.
- 11.2.17. ICON Plc
12. 360 Degree Analyst View
13. Appendix
- 13.1. Research Methodology
- 13.2. References
- 13.3. Abbreviations
- 13.4. Disclaimer
- 13.5. Contact Us
Product Code: ANV1515
List of Tables
- TABLE List of data sources
- TABLE Market drivers; Impact Analysis
- TABLE Market restraints; Impact Analysis
- TABLE Biopharmaceutical CMO And CRO Market: Product type Snapshot (2022)
- TABLE Segment Dashboard; Definition and Scope, by Product type
- TABLE Global Biopharmaceutical CMO And CRO Market, by Product type 2018-2030 (USD Million)
- TABLE Biopharmaceutical CMO And CRO Market: Source Snapshot (2022)
- TABLE Segment Dashboard; Definition and Scope, by Source
- TABLE Global Biopharmaceutical CMO And CRO Market, by Source 2018-2030 (USD Million)
- TABLE Biopharmaceutical CMO And CRO Market: Service Type Snapshot (2022)
- TABLE Segment Dashboard; Definition and Scope, by Service Type
- TABLE Global Biopharmaceutical CMO And CRO Market, by Service Type 2018-2030 (USD Million)
- TABLE Biopharmaceutical CMO And CRO Market: Regional snapshot (2022)
- TABLE Segment Dashboard; Definition and Scope, by Region
- TABLE Global Biopharmaceutical CMO And CRO Market, by Region 2018-2030 (USD Million)
- TABLE North America Biopharmaceutical CMO And CRO Market, by Country, 2018-2030 (USD Million)
- TABLE North America Biopharmaceutical CMO And CRO Market, by Product type, 2018-2030 (USD Million)
- TABLE North America Biopharmaceutical CMO And CRO Market, by Source, 2018-2030 (USD Million)
- TABLE North America Biopharmaceutical CMO And CRO Market, by Service Type, 2018-2030 (USD Million)
- TABLE Europe Biopharmaceutical CMO And CRO Market, by Country, 2018-2030 (USD Million)
- TABLE Europe Biopharmaceutical CMO And CRO Market, by Product type, 2018-2030 (USD Million)
- TABLE Europe Biopharmaceutical CMO And CRO Market, by Source, 2018-2030 (USD Million)
- TABLE Europe Biopharmaceutical CMO And CRO Market, by Service Type, 2018-2030 (USD Million)
- TABLE Asia Pacific Biopharmaceutical CMO And CRO Market, by Country, 2018-2030 (USD Million)
- TABLE Asia Pacific Biopharmaceutical CMO And CRO Market, by Product type, 2018-2030 (USD Million)
- TABLE Asia Pacific Biopharmaceutical CMO And CRO Market, by Source, 2018-2030 (USD Million)
- TABLE Asia Pacific Biopharmaceutical CMO And CRO Market, by Service Type, 2018-2030 (USD Million)
- TABLE Latin America Biopharmaceutical CMO And CRO Market, by Country, 2018-2030 (USD Million)
- TABLE Latin America Biopharmaceutical CMO And CRO Market, by Product type, 2018-2030 (USD Million)
- TABLE Latin America Biopharmaceutical CMO And CRO Market, by Source, 2018-2030 (USD Million)
- TABLE Latin America Biopharmaceutical CMO And CRO Market, by Service Type, 2018-2030 (USD Million)
- TABLE Middle East and Africa Biopharmaceutical CMO And CRO Market, by Country, 2018-2030 (USD Million)
- TABLE Middle East and Africa Biopharmaceutical CMO And CRO Market, by Product type, 2018-2030 (USD Million)
- TABLE Middle East and Africa Biopharmaceutical CMO And CRO Market, by Source, 2018-2030 (USD Million)
- TABLE Middle East and Africa Biopharmaceutical CMO And CRO Market, by Service Type, 2018-2030 (USD Million)
List of Figures
- FIGURE Biopharmaceutical CMO And CRO Market Segmentation
- FIGURE Market research methodology
- FIGURE Value chain analysis
- FIGURE Porter's Five Forces Analysis
- FIGURE Market Attractiveness Analysis
- FIGURE COVID-19 Impact Analysis
- FIGURE Pre & Post COVID-19 Impact Comparision Study
- FIGURE Competitive Landscape; Key company market share analysis, 2022
- FIGURE Product type segment market share analysis, 2022 & 2030
- FIGURE Product type segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
- FIGURE Source segment market share analysis, 2022 & 2030
- FIGURE Source segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
- FIGURE Service Type segment market share analysis, 2022 & 2030
- FIGURE Service Type segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
- FIGURE Regional segment market share analysis, 2022 & 2030
- FIGURE Regional segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
- FIGURE North America Biopharmaceutical CMO And CRO Market share and leading players, 2022
- FIGURE Europe Biopharmaceutical CMO And CRO Market share and leading players, 2022
- FIGURE Asia Pacific Biopharmaceutical CMO And CRO Market share and leading players, 2022
- FIGURE Latin America Biopharmaceutical CMO And CRO Market share and leading players, 2022
- FIGURE Middle East and Africa Biopharmaceutical CMO And CRO Market share and leading players, 2022
- FIGURE North America market share analysis by country, 2022
- FIGURE U.S. Biopharmaceutical CMO And CRO Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
- FIGURE Canada Biopharmaceutical CMO And CRO Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
- FIGURE Europe Biopharmaceutical CMO And CRO Market share analysis by country, 2022
- FIGURE Germany Biopharmaceutical CMO And CRO Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
- FIGURE Spain Biopharmaceutical CMO And CRO Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
- FIGURE Italy Biopharmaceutical CMO And CRO Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
- FIGURE France Biopharmaceutical CMO And CRO Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
- FIGURE UK Biopharmaceutical CMO And CRO Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
- FIGURE Russia Biopharmaceutical CMO And CRO Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
- FIGURE Netherlands Biopharmaceutical CMO And CRO Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
- FIGURE Sweden Biopharmaceutical CMO And CRO Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
- FIGURE Poland Biopharmaceutical CMO And CRO Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
- FIGURE Rest of the Europe Biopharmaceutical CMO And CRO Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
- FIGURE Asia Pacific Biopharmaceutical CMO And CRO Market share analysis by country, 2022
- FIGURE India Biopharmaceutical CMO And CRO Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
- FIGURE China Biopharmaceutical CMO And CRO Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
- FIGURE Japan Biopharmaceutical CMO And CRO Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
- FIGURE South Korea Biopharmaceutical CMO And CRO Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
- FIGURE Australia Biopharmaceutical CMO And CRO Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
- FIGURE Thailand Biopharmaceutical CMO And CRO Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
- FIGURE Indonesia Biopharmaceutical CMO And CRO Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
- FIGURE Phillipines Biopharmaceutical CMO And CRO Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
- FIGURE Rest of APAC Biopharmaceutical CMO And CRO Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
- FIGURE Latin America Biopharmaceutical CMO And CRO Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
- FIGURE Latin America Biopharmaceutical CMO And CRO Market share analysis by country, 2022
- FIGURE Brazil Biopharmaceutical CMO And CRO Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
- FIGURE Mexico Biopharmaceutical CMO And CRO Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
- FIGURE Argentina Biopharmaceutical CMO And CRO Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
- FIGURE Colombia Biopharmaceutical CMO And CRO Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
- FIGURE Rest of LATAM Biopharmaceutical CMO And CRO Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
- FIGURE Middle East and Africa Biopharmaceutical CMO And CRO Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
- FIGURE Middle East and Africa Biopharmaceutical CMO And CRO Market share analysis by country, 2022
- FIGURE Saudi Arabia Biopharmaceutical CMO And CRO Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
- FIGURE United Arab Emirates Biopharmaceutical CMO And CRO Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
- FIGURE Israel Biopharmaceutical CMO And CRO Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
- FIGURE Turkey Biopharmaceutical CMO And CRO Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
- FIGURE Algeria Biopharmaceutical CMO And CRO Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
- FIGURE Egypt Biopharmaceutical CMO And CRO Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
- FIGURE Rest of MEA Biopharmaceutical CMO And CRO Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
Have a question?
SELECT AN OPTION
Have a question?
Questions? Please give us a call or visit the contact form.